Craft

PURE Bioscience

Stock Price

$0.1

2024-10-29

Market Capitalization

$10.1 M

2024-10-29

Revenue

$2.2 M

FY, 2025

PURE Bioscience Summary

Company Summary

Overview
PURE Bioscience is a company developing and commercializing antimicrobial products. It develops a technology platform based on stabilized ionic silver and products containing silver dihydrogen citrate (SDC). In addition, the Company manufactures and distributes SDC-based disinfecting and sanitizing products. It produces and supplies SDC-based formulations for the production of personal care products.
Type
Public
Status
Active
Founded
1992
HQ
Rancho Cucamonga, CA, US | view all locations
Website
https://www.purebio.com/
Cybersecurity rating
ESG rating
30-39 out of 100|View all ESG data
Sectors

Key People

  • Ivan Chen

    Ivan Chen, Chairman of the Board

  • Mark Elliott, Vice President, Finance

    • Tom Myers, Executive Vice President, Technology and Development & Board Member

      • Kristin A. Taylor, Board Member

        LocationsView all

        3 locations detected

        • Rancho Cucamonga, CA HQ

          United States

          9669 Hermosa Ave

        • El Cajon, CA

          United States

          1725 Gillespie Way

        • El Cajon, CA

          United States

          771 Jamacha Road #512

        PURE Bioscience Financials

        Summary Financials

        Revenue (Q2, 2026)
        $443.0K
        Gross profit (Q2, 2026)
        $238.0K
        Net income (Q2, 2026)
        ($785.0K)
        Cash (Q2, 2026)
        $198.0K
        EBIT (Q2, 2026)
        ($683.0K)

        Footer menu